The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo.
Bioorg Chem
; 131: 106328, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36542986
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Focal Adhesion Protein-Tyrosine Kinases
/
Histone Deacetylase Inhibitors
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Bioorg Chem
Year:
2023
Document type:
Article